Dec. 11, 2024 — Genetesis, Inc. has launched the CardioFlux Membership program. CardioFlux Membership is designed to be ...
Dec. 12, 2024 — Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and ...
Dec. 13, 2024 – Sensome has announced positive results from two studies of its Clotild Smart Guidewire System ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Bally Ribbon Mills (BRM) offers a broad product line of medical textiles and fabrics ideal for use in cardiovascular ...
Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 ...
Nov. 18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...
Nov. 21, 2024 — Royal Philips plans to unveil its next-generation 1.5T BlueSeal MR wide-bore scanner at RSNA 2024 in ...
Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...
Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific ...
The deadline for early bird discounts for HIMSS25 is rapidly approaching. Register by December 15 to save up to $500 on ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Nov. 13, 2024 – A recent study has demonstrated the value of the single-exposure dual-energy X-ray detector in advancing ...
Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...
Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular ...
December 18, 2024
